Literature DB >> 19464599

The classification of cutaneous melanoma.

Lyn McDivitt Duncan1.   

Abstract

Forty years ago, a clinical and histological classification scheme and prognostic factors were described for cutaneous melanoma. This scheme included the subtypes superficial spreading, nodular and lentigo maligna, and prognostic factors including tumor thickness, ulceration, and mitotic activity. There have been some tweaks to the classification scheme, but these basic findings form the foundation for melanoma diagnosis and staging today. Currently, no molecular marker or target has proved reliably useful in the staging or treatment of melanoma. Measurement with a simple ruler serves as the basis for the staging of primary cutaneous melanoma, while the recognition of primary tumor mitotic activity and ulceration also remain significant factors. Recently, mutational analysis has revealed a correlation of activating mutations with the morphological descriptors from decades ago. Future classification schemes may have more power in predicting response to therapy by integrating specific genomic and intra-tumoral expression profiles with histologic findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464599     DOI: 10.1016/j.hoc.2009.03.013

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  17 in total

Review 1.  Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management.

Authors:  Dongying Wang; Tianmin Xu; He Zhu; Junxue Dong; Li Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Authors:  Rajmohan Murali; Chris Goumas; Anne Kricker; Lynn From; Klaus J Busam; Colin B Begg; Terence Dwyer; Stephen B Gruber; Peter A Kanetsky; Irene Orlow; Stefano Rosso; Nancy E Thomas; Marianne Berwick; Richard A Scolyer; Bruce K Armstrong
Journal:  Ann Surg Oncol       Date:  2011-09-13       Impact factor: 5.344

3.  Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Authors:  Marina Kvaskoff; David C Whiteman; Zhen Z Zhao; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward; David L Duffy
Journal:  Twin Res Hum Genet       Date:  2011-10       Impact factor: 1.587

Review 4.  CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.

Authors:  Maxime Barat; Sarah Guegan-Bart; Anne-Ségolène Cottereau; Enora Guillo; Christine Hoeffel; Maximilien Barret; Sébastien Gaujoux; Anthony Dohan; Philippe Soyer
Journal:  Abdom Radiol (NY)       Date:  2020-11-02

5.  Histology-specific microRNA alterations in melanoma.

Authors:  Laura Poliseno; Adele Haimovic; Miguel F Segura; Douglas Hanniford; Paul J Christos; Farbod Darvishian; Jinhua Wang; Richard L Shapiro; Anna C Pavlick; Russell S Berman; Eva Hernando; Jiri Zavadil; Iman Osman
Journal:  J Invest Dermatol       Date:  2012-05-03       Impact factor: 8.551

6.  Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.

Authors:  Michael Lattanzi; Yesung Lee; Danny Simpson; Una Moran; Farbod Darvishian; Randie H Kim; Eva Hernando; David Polsky; Doug Hanniford; Richard Shapiro; Russell Berman; Anna C Pavlick; Melissa A Wilson; Tomas Kirchhoff; Jeffrey S Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 7.  The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation.

Authors:  Dong-Dong Jia; Hui Jiang; Yi-Fei Zhang; Yu Zhang; Li-Li Qian; Yin-Feng Zhang
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

8.  Non-Metastatic Cutaneous Melanoma Induces Chronodisruption in Central and Peripheral Circadian Clocks.

Authors:  Leonardo Vinícius Monteiro de Assis; Maria Nathália Moraes; Keila Karoline Magalhães-Marques; Gabriela Sarti Kinker; Sanseray da Silveira Cruz-Machado; Ana Maria de Lauro Castrucci
Journal:  Int J Mol Sci       Date:  2018-04-03       Impact factor: 5.923

Review 9.  Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy.

Authors:  Paola M Dantonio; Marianne O Klein; Maria Renata V B Freire; Camila N Araujo; Ana Carolina Chiacetti; Ricardo G Correa
Journal:  Biosci Rep       Date:  2018-10-02       Impact factor: 3.840

10.  A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants.

Authors:  Ivana Ticha; Jan Hojny; Romana Michalkova; Ondrej Kodet; Eva Krkavcova; Nikola Hajkova; Kristyna Nemejcova; Michaela Bartu; Radek Jaksa; Miroslav Dura; Madiha Kanwal; Andra S Martinikova; Libor Macurek; Petra Zemankova; Zdenek Kleibl; Pavel Dundr
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.